Trial backs role for Lynparza in secondline prostate cancer

Trial backs role for Lynparza in second-line prostate cancer

06:26 EDT 7 Aug 2019 | PMLIVE

Demonstrates potential significant benefit in treatment of disease

Original Article: Trial backs role for Lynparza in second-line prostate cancer

More From BioPortfolio on "Trial backs role for Lynparza in second-line prostate cancer"